No group fared particularly well in an analysis from Trilliant Health looking at publicly reported data. Most of the new utilization of mental health services was for anxiety, with women seeking care most often.

U.S. healthcare gets plenty of bang for its buck out of community health workers (CHWs), according to a systematic review of the relevant published research. 

The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.

When preparing for life as both doctors and parents, new mothers and mothers-to-be suffer significantly less burnout if they’re supported by targeted, well-planned support. 

Researchers warn of potential perdition—so to speak—for doing algorithmic medicine wrong in any of these easily avoidable ways. 

The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.

Good Samaritan Regional Medical Center is named in a court filing against a physician at the facility who allegedly failed to clean a wound, leaving 12 pieces of twigs, moss and pine needles inside. The alleged victim, an 18-year-old man, later died.

A meticulous comparison of quality-of-life factors across 100 countries has yielded good news and bad news for the United States of America.

The New Jersey-based drug developer joins AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer in offering products directly to patients at a discounted rate. Johnson & Johnson is currently listing four medications on the platform.

Frustratingly to hospital leadership, the upward trajectory in attacks and harms is happening despite healthcare’s striving—and spending—to be more proactive with defensive measures.

The company keeps gaining momentum thanks to the success of its AI-powered imaging software. 

“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.